Goldman Sachs’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.01M Sell
94,270
-51,064
-35% -$4.11M ﹤0.01% 3454
2026
Q1
$11M Buy
145,334
+49,866
+52% +$3.67M ﹤0.01% 2998
2025
Q4
$6.48M Buy
95,468
+1,553
+2% +$97K ﹤0.01% 3511
2025
Q3
$5.36M Sell
93,915
-65,324
-41% -$3.87M ﹤0.01% 3571
2025
Q2
$8.82M Sell
159,239
-33,934
-18% -$1.59M ﹤0.01% 2872
2025
Q1
$8.45M Sell
193,173
-52,010
-21% -$2.27M ﹤0.01% 2856
2024
Q4
$10.6M Sell
245,183
-278,476
-53% -$12.5M ﹤0.01% 2753
2024
Q3
$23.4M Buy
523,659
+291,815
+126% +$12.1M ﹤0.01% 1923
2024
Q2
$8.92M Sell
231,844
-148,464
-39% -$5.66M ﹤0.01% 2605
2024
Q1
$13.1M Buy
380,308
+55,417
+17% +$1.78M ﹤0.01% 2230
2023
Q4
$9.41M Sell
324,891
-45,467
-12% -$1.04M ﹤0.01% 2594
2023
Q3
$7.01M Buy
+370,358
New +$7.03M ﹤0.01% 2693

Other funds holding DBD

Goldman Sachs's DBD Position: Q2 2026 in Review

Goldman Sachs reduced its Diebold Nixdorf (DBD) stake by 35% in Q2 2026, selling an estimated $4.11M and leaving 94,270 shares worth $8.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

Goldman Sachs first reported a position in DBD in Q3 2023 and has held it in 12 quarters since. The position peaked at $23.4M in Q3 2024. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Goldman Sachs held 94,270 shares of Diebold Nixdorf worth $8.01M as of Q2 2026.
  • Goldman Sachs sold 51,064 Diebold Nixdorf shares in Q2 2026, an estimated $4.11M.
  • Diebold Nixdorf made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3454 holding.
  • Goldman Sachs first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 12 quarters since.
  • Goldman Sachs's Diebold Nixdorf position peaked at $23.4M in Q3 2024.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.